Clear Harbor Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.85M | Sell |
27,214
-6,120
| -18% | -$1.32M | 0.42% | 50 |
|
|
2026
Q1 | $7.25M | Sell |
33,334
-154
| -0.5% | -$34.2K | 0.5% | 46 |
|
|
2025
Q4 | $7.65M | Sell |
33,488
-95
| -0.3% | -$21.6K | 0.52% | 45 |
|
|
2025
Q3 | $7.78M | Sell |
33,583
-2,797
| -8% | -$570K | 0.54% | 44 |
|
|
2025
Q2 | $6.75M | Sell |
36,380
-520
| -1% | -$96.6K | 0.51% | 45 |
|
|
2025
Q1 | $7.73M | Buy |
36,900
+585
| +2% | +$114K | 0.61% | 38 |
|
|
2024
Q4 | $6.45M | Buy |
36,315
+3,042
| +9% | +$559K | 0.51% | 46 |
|
|
2024
Q3 | $6.57M | Buy |
33,273
+816
| +3% | +$152K | 0.53% | 44 |
|
|
2024
Q2 | $5.57M | Sell |
32,457
-101
| -0.3% | -$16.7K | 0.48% | 54 |
|
|
2024
Q1 | $5.93M | Sell |
32,558
-633
| -2% | -$109K | 0.52% | 44 |
|
|
2023
Q4 | $5.14M | Sell |
33,191
-869
| -3% | -$127K | 0.47% | 48 |
|
|
2023
Q3 | $5.08M | Sell |
34,060
-100
| -0.3% | -$14.7K | 0.53% | 40 |
|
|
2023
Q2 | $4.6M | Buy |
34,160
+5,166
| +18% | +$758K | 0.45% | 52 |
|
|
2023
Q1 | $4.62M | Buy |
28,994
+14,648
| +102% | +$2.24M | 0.48% | 43 |
|
|
2022
Q4 | $2.32M | Hold |
14,346
| – | – | 0.29% | 74 |
|
|
2022
Q3 | $1.93M | Sell |
14,346
-50
| -0.3% | -$7.17K | 0.27% | 71 |
|
|
2022
Q2 | $2.21M | Sell |
14,396
-40
| -0.3% | -$6.11K | 0.29% | 67 |
|
|
2022
Q1 | $2.34M | Sell |
14,436
-1,355
| -9% | -$197K | 0.27% | 71 |
|
|
2021
Q4 | $2.14M | Sell |
15,791
-78
| -0.5% | -$9.21K | 0.23% | 85 |
|
|
2021
Q3 | $1.71M | Buy |
15,869
+263
| +2% | +$30.1K | 0.03% | 107 |
|
|
2021
Q2 | $1.76M | Buy |
15,606
+30
| +0.2% | +$3.38K | 0.21% | 94 |
|
|
2021
Q1 | $1.69M | Buy |
15,576
+323
| +2% | +$34.5K | 0.22% | 91 |
|
|
2020
Q4 | $1.63M | Sell |
15,253
-177
| -1% | -$17K | 0.23% | 78 |
|
|
2020
Q3 | $1.35M | Hold |
15,430
| – | – | 0.23% | 78 |
|
|
2020
Q2 | $1.51M | Buy |
15,430
+3,358
| +28% | +$296K | 0.29% | 69 |
|
|
2020
Q1 | $920K | Buy |
12,072
+500
| +4% | +$42.6K | 0.21% | 85 |
|
|
2019
Q4 | $1.02M | Buy |
11,572
+1,500
| +15% | +$125K | 0.18% | 100 |
|
|
2019
Q3 | $763K | Hold |
10,072
| – | – | 0.15% | 109 |
|
|
2019
Q2 | $732K | Hold |
10,072
| – | – | 0.15% | 106 |
|
|
2019
Q1 | $812K | Hold |
10,072
| – | – | 0.16% | 99 |
|
|
2018
Q4 | $929K | Buy |
10,072
+37
| +0.4% | +$3.25K | 0.21% | 86 |
|
|
2018
Q3 | $820K | Hold |
10,035
| – | – | 0.17% | 104 |
|
|
2018
Q2 | $930K | Hold |
10,035
| – | – | 0.17% | 101 |
|
|
2018
Q1 | $950K | Buy |
10,035
+195
| +2% | +$21.4K | 0.19% | 97 |
|
|
2017
Q4 | $952K | Buy |
9,840
+400
| +4% | +$37.7K | 0.18% | 97 |
|
|
2017
Q3 | $839K | Hold |
9,440
| – | – | 0.17% | 103 |
|
|
2017
Q2 | $679K | Hold |
9,440
| – | – | 0.13% | 116 |
|
|
2017
Q1 | $615K | Buy |
9,440
+1,400
| +17% | +$88K | 0.12% | 118 |
|
|
2016
Q4 | $503K | Sell |
8,040
-9,872
| -55% | -$603K | 0.11% | 130 |
|
|
2016
Q3 | $1.13M | Hold |
17,912
| – | – | 0.25% | 83 |
|
|
2016
Q2 | $1.11M | Sell |
17,912
-900
| -5% | -$54.8K | 0.24% | 85 |
|
|
2016
Q1 | $1.07M | Buy |
18,812
+247
| +1% | +$13.8K | 0.24% | 86 |
|
|
2015
Q4 | $1.1M | Sell |
18,565
-2,287
| -11% | -$132K | 0.25% | 79 |
|
|
2015
Q3 | $1.14M | Sell |
20,852
-603
| -3% | -$39.3K | 0.26% | 76 |
|
|
2015
Q2 | $1.44M | Buy |
21,455
+1,175
| +6% | +$76.7K | 0.28% | 82 |
|
|
2015
Q1 | $1.19M | Buy |
20,280
+7,970
| +65% | +$481K | 0.23% | 92 |
|
|
2014
Q4 | $806K | Buy |
12,310
+200
| +2% | +$12.6K | 0.16% | 119 |
|
|
2014
Q3 | $699K | Hold |
12,110
| – | – | 0.16% | 106 |
|
|
2014
Q2 | $683K | Hold |
12,110
| – | – | 0.15% | 104 |
|
|
2014
Q1 | $622K | Hold |
12,110
| – | – | 0.15% | 114 |
|
|
2013
Q4 | $640K | Hold |
12,110
| – | – | 0.16% | 106 |
|
|
2013
Q3 | $542K | Buy |
12,110
+470
| +4% | +$20.8K | 0.15% | 99 |
|
|
2013
Q2 | $481K | Buy |
+11,640
| New | +$509K | 0.14% | 108 |
|
Other funds holding ABBV
Clear Harbor Asset Management's ABBV Position: Q2 2026 in Review
Clear Harbor Asset Management reduced its AbbVie (ABBV) stake by 18% in Q2 2026, selling an estimated $1.32M and leaving 27,214 shares worth $6.85M. The position accounts for 0.42% of the portfolio, ranked #50.
Clear Harbor Asset Management first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $7.78M in Q3 2025. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Clear Harbor Asset Management held 27,214 shares of AbbVie worth $6.85M as of Q2 2026.
- Clear Harbor Asset Management sold 6,120 AbbVie shares in Q2 2026, an estimated $1.32M.
- AbbVie made up 0.42% of Clear Harbor Asset Management's portfolio in Q2 2026, its #50 holding.
- Clear Harbor Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- Clear Harbor Asset Management's AbbVie position peaked at $7.78M in Q3 2025.
- 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Clear Harbor Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.